IL88375A - נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ - Google Patents

נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ

Info

Publication number
IL88375A
IL88375A IL8837588A IL8837588A IL88375A IL 88375 A IL88375 A IL 88375A IL 8837588 A IL8837588 A IL 8837588A IL 8837588 A IL8837588 A IL 8837588A IL 88375 A IL88375 A IL 88375A
Authority
IL
Israel
Prior art keywords
ifn
cells
recombinant
expressed
protein
Prior art date
Application number
IL8837588A
Other languages
English (en)
Other versions
IL88375A0 (en
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL8837588A priority Critical patent/IL88375A/he
Priority to CA000617131A priority patent/CA1341253C/en
Priority to CA000589005A priority patent/CA1341588C/en
Priority to EP89101295A priority patent/EP0326120B1/en
Priority to DE68928641T priority patent/DE68928641T2/de
Priority to JP1016080A priority patent/JP2725818B2/ja
Priority to AU28813/89A priority patent/AU621852B2/en
Priority to AT89101295T priority patent/ATE165010T1/de
Priority to ES89101295T priority patent/ES2119735T3/es
Publication of IL88375A0 publication Critical patent/IL88375A0/xx
Priority to US07/436,321 priority patent/US5618700A/en
Publication of IL88375A publication Critical patent/IL88375A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL8837588A 1988-01-26 1988-11-14 נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ IL88375A (he)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL8837588A IL88375A (he) 1988-11-14 1988-11-14 נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ
CA000617131A CA1341253C (en) 1988-01-26 1989-01-24 Human ifn-.beta.2/il-6, its purification and use
CA000589005A CA1341588C (en) 1988-01-26 1989-01-24 Human ifn-beta2/i1-6, its purification and use
JP1016080A JP2725818B2 (ja) 1988-01-26 1989-01-25 ヒトインターフエロンベーター２、その精製法及びその用途
DE68928641T DE68928641T2 (de) 1988-01-26 1989-01-25 Menschliches IFN-beta2/IL-6, dessen Reinigung und Verwendungen
EP89101295A EP0326120B1 (en) 1988-01-26 1989-01-25 Human IFN-beta2/IL-6, its purification and uses
AU28813/89A AU621852B2 (en) 1988-01-26 1989-01-25 Human ifn-beta 2/il-6, its purification and use
AT89101295T ATE165010T1 (de) 1988-01-26 1989-01-25 Menschliches ifn-beta2/il-6, dessen reinigung und verwendungen
ES89101295T ES2119735T3 (es) 1988-01-26 1989-01-25 Ifn-beta2/il-6 humano, su purificacion y sus utilizaciones.
US07/436,321 US5618700A (en) 1988-11-14 1989-11-14 IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL8837588A IL88375A (he) 1988-11-14 1988-11-14 נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ

Publications (2)

Publication Number Publication Date
IL88375A0 IL88375A0 (en) 1989-06-30
IL88375A true IL88375A (he) 1995-07-31

Family

ID=11059415

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8837588A IL88375A (he) 1988-01-26 1988-11-14 נוגדנים מונוקלונליים הקושרים ספציפית אינטרפרון- ביא 2 טבעי ורקומביננטי ושיטה לטיהור אינטרפרון-ביטא 2 טבעי ורקומביננטי ושיטה לטיהור אינ

Country Status (2)

Country Link
US (1) US5618700A (he)
IL (1) IL88375A (he)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856135A (en) * 1993-05-31 1999-01-05 Chugai Seiyaku Kabushiki Kaisha Reshaped human antibody to human interleukin-6
RU2318829C2 (ru) * 2001-11-14 2008-03-10 Сентокор, Инк. Антитела против il-6, композиции, способы и применение
US20050100550A1 (en) * 2003-11-10 2005-05-12 Mohit Trikha Anti-angiogenic uses of IL-6 antagonists
PA8672101A1 (es) * 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
CN101356194B (zh) * 2005-12-09 2013-06-12 Ucb医药有限公司 对人il-6具有特异性的抗体分子
AU2007282023B2 (en) * 2006-08-03 2012-09-13 Vaccinex, Inc. Anti-IL-6 monoclonal antibodies and uses thereof
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
KR20100028571A (ko) * 2007-05-21 2010-03-12 앨더 바이오파마슈티컬즈, 인코포레이티드 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
CN101754772B (zh) 2007-05-21 2015-08-19 奥尔德生物控股有限责任公司 针对il-6的抗体及其用途
US8404235B2 (en) * 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
CA2724279C (en) * 2008-05-13 2017-03-07 Novimmune S.A. Anti-il-6/il-6r antibodies and methods of use thereof
US8188235B2 (en) * 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses
KR20110094307A (ko) * 2008-11-13 2011-08-23 펨타 파마슈티컬스, 인크. 인간화된 항-ｉｌ-6 항체
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
EP2504032A4 (en) 2009-11-24 2013-06-19 Alderbio Holdings Llc IL-6 ANTAGONISTS FOR PREVENTING OR TREATING THROMBOSIS
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
CA2818814A1 (en) 2010-11-23 2012-05-31 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of anemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
JPS59172496A (ja) * 1983-03-18 1984-09-29 Kyowa Hakko Kogyo Co Ltd モノクロ−ナル抗体
JP2598666B2 (ja) * 1987-10-19 1997-04-09 忠三 岸本 抗ヒトｂｃｄｆモノクローナル抗体

Also Published As

Publication number Publication date
IL88375A0 (en) 1989-06-30
US5618700A (en) 1997-04-08

Similar Documents

Publication Publication Date Title
US5618700A (en) IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same
KR920002267B1 (ko) 하이브리드 인터페론의 제조방법
JP2725818B2 (ja) ヒトインターフエロンベーター２、その精製法及びその用途
Brakenhoff et al. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino-and carboxyl-terminal deletion mutants.
US5011912A (en) Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
CA2022610C (en) Human gp130 protein
EP0370989B1 (en) Human vascular permeability factor
AU643189B2 (en) Production of chimeric mouse-human antibodies with specificity to human tumor antigens
CA1335653C (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
EP0335899A4 (en) IMMUNAFFINITY CLEANING SYSTEM.
Kasahara et al. Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha).
US4599306A (en) Monoclonal antibodies which specifically bind to human immune interferon
NZ222939A (en) Human interleukin-3, production using genetic engineering methods, antibodies to human interleukin-3 and screening of dna library with 3' untranslated region
US4845198A (en) Hybridoma antibody which binds IL-2 receptor
US5763210A (en) Recombinant production of interferon-gamma binding proteins
US5644035A (en) Method for purifying secreted Mac-2-binding glycoprotein
Berg Identification, production, and characterization of murine monoclonal antibody (LO-22) recognizing 12 native species of human alpha interferon
Novick et al. Monoclonal antibodies for affinity purification of IL-6/IFN-β2 and for neutralization of HGF activity
KR100382628B1 (ko) 인터페론α/β결합단백질과이의제조및용도
Sugasawara Hybridoma growth factors
Conlon et al. Generation of anti-peptide monoclonal antibodies which recognize mature CSF-2 alpha (IL 3) protein.
AU651139B2 (en) Human IFN-beta 2/IL-6, its purification and use
CA1341253C (en) Human ifn-.beta.2/il-6, its purification and use
Giles et al. Intrasubunit homogeneity in heterogeneous IgM antibodies to the DNP moiety derived from a murine hybridoma cell line
Tsukui et al. Two monoclonal antibodies distinguish between human recombinant interferon-α5s produced by Escherichia coli and by mouse cells

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired